CAMCEVI
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87953162
- Registration number
- 6725089
- Mark type
- Stylized text
- Filed
- 07 Jun 2018
- Published for opposition
- 13 Nov 2018
- Registered
- 24 May 2022
- Attorney of record
- Salvatore Guerriero
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, leuprolide mesylate injectable suspension
Owner
- FORESEE PHARMACEUTICALS, Co LTD., Taipei City 115, TW
- FORESEE PHARMACEUTICALS, Co LTD., Taipei City 115, TW
- FORESEE PHARMACEUTICALS, Co LTD., Taipei City 115, TW
Prosecution history
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Jan 2022 — USE AMENDMENT FILED
- 28 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jan 2022 — TEAS STATEMENT OF USE RECEIVED
- 26 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jun 2021 — SOU EXTENSION 5 GRANTED
- 17 Jun 2021 — SOU EXTENSION 5 FILED
- 23 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS